Home/Minutia/Katy Digovich
KD

Katy Digovich

CEO

Minutia

Therapeutic Areas

Minutia Pipeline

DrugIndicationPhase
Monitored Cell Transplant for DiabetesDiabetes (Type 1)Pre-clinical